Kunal Shah
Allergy & Immunology · Round Hill, VANPI 1477714004
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 274 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 24.9% of the total.
Across 274 payments — averaging $25.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Pfizer$585
- Sanofi$562
- Merz North America, Inc.$523
- GSK$341
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,65594%
- Education$4036%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 74 | $1,756 |
| Regeneron Healthcare Solutions, Inc. | 49 | $1,414 |
| Pfizer | 38 | $585 |
| Sanofi | 18 | $562 |
| Merz North America, Inc. | 5 | $523 |
| GSK | 19 | $341 |
| Incyte Corporation | 7 | $266 |
| Sanofi-aventis U.S. LLC | 3 | $249 |
| Boehringer Ingelheim | 6 | $217 |
| Kaleo, Inc. | 11 | $210 |
| Alk-abello, Inc | 11 | $187 |
| AbbVie | 4 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Novartis | 4 | $95 |
| CSL Behring | 3 | $69 |
| Genentech USA, Inc. | 3 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Grifols USA, LLC | 1 | $25 |
| Octapharma USA, Inc. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,058 in reported general payments places this provider in the 60th percentile of 133 allergy & immunology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 16 | $86 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Round Hill
- Charles LaneLynchburg$1.4M
- Jacqueline Eghrari-SabetVienna$1M
- Eric KarlinWilliamsburg$522K
- Nicholas RiderRoanoke$227K
- Courtney BlairMc Lean$139K
- Andrew KimFredericksburg$104K
- Behnam DaghighLeesburg$99K
- Ananth ThyagarajanBurke$97K
- Larry BorishCharlottesville$92K
- Oral AlpanSpringfield$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.